Conversely, other studies suggest that YTHDF1 may promote mRNA degradation, as all three YTHDF proteins (YTHDF1‐3) share highly similar domain structures and interact with the CCR4‐NOT RNA degradation complex.[47, 48] Our data suggest that YTHDF1‐3 exhibit similar effects in gastric cancer, particularly within interferon gamma signaling, as demonstrated by gene set enrichment analysis (Figure S5, Supporting Information). The gene discussed is IFNG; the disease is gastric cancer.